Dietary fat and prostate cancer: Current status

Journal of the National Cancer Institute

Volumn 91, Issue 5, 1999, Pages 414-428

  Kolonel, Laurence N ^a   Nomura, Abraham M Y ^a   Cooney, Robert V ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; SATURATED FATTY ACID; UNSATURATED FATTY ACID;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHOLESTEROL BLOOD LEVEL; DISEASE PREDISPOSITION; DNA DAMAGE; FAT INTAKE; FATTY ACID BLOOD LEVEL; HEREDITY; NUTRITION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; RISK MANAGEMENT; TUMOR GROWTH;

EID: 0033518876     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.5.414     Document Type: Review

References (190)

1. Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev 1991;13:200-27.
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol. VII. Lyon (France): IARC Sci Publ No. 143; 1997. p. 316.
3. Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D, et al., editors. Racial/ethnic patterns of cancer in the United States 1988-1992. National Cancer Institute. NIH Publ No. 96-4104. Bethesda (MD), 1996.
4. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995;1:827-9.
5. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-47.
6. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739-44.
7. Meikle AW, Stanish WM. Familial prostatic cancer risk and low testosterone. J Clin Endocrinol Metab 1982;54:1104-08.
8. Ford LG, Brawley OW, Perlman JA, Nayfield SG, Johnson KA, Kramer BS. The potential for hormonal prevention trials. Cancer 1994;74(9 Suppl):2726-33.
9. DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia (PA): Lippincott; 1985. p. 951-3.
10. Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, et al. A prevalent missense substitution that modulates activity of prostatic steroid 5α-reductase. Cancer Res 1997;57:1020-2.
11. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89: 166-70.
12. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997;57:1194-8.
13. Kolonel LN. Racial and geographic variations in prostate cancer and the effect of migration. In: Fortner JG, Sharp PA, editors. Accomplishments in cancer research, 1996. Philadelphia (PA): Lippincott-Raven; 1997. p. 221-30.
14. Hartoma TR, Nahoul K, Netter A. Zinc, plasma, androgens and male sterility [letter]. Lancet 1977;2:1125-6.
15. Hill P, Wynder EL, Garbaczewski L, Games H, Walker AR. Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 1979;39:5101-5.
16. Dorgan JF, Judd JT, Longcope C, Brown C, Sahatzkin A, Clevidence BA, et al. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 1996;64: 850-5.
17. Committee on Diet, Nutrition and Cancer. Diet, nutrition and cancer. National Research Council. Washington (DC); National Academy Press; 1982; p. 5-2.
18. Committee on Diet and Health. Diet and health. Institute of Medicine, Washington (DC): National Academy Press; 1989.
19. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington (DC): American Institute for Cancer Research; 1997.
20. Stryer L. Fatty acid metabolism. In: Biochemistry. New York (NY): Freeman; 1995. p. 603-28.
21. Ascherio A, Willett WC. Health effects of trans fatty acids. Am J Clin Nutr 1997;66(4 Suppl):1006s-1010s.
22. Huang SC, Fritsche KL. Alteration in mouse splenic phospholipid fatty acid composition and lymphoid cell populations by dietary fat. Lipids 1992;27:25-32
23. Pulido JA, del Hoyo N, Perez-Albarsanz MA. Composition and fatty acid content of rat ventral prostate phospholipids. Biochim Biophys Acta 1986; 879:51-5.
24. Phinney SD, Stern JS, Burke KE, Tang AB, Miller G, Holman RT. Human subcutaneous adipose tissue shows site-specific differences in fatty acid composition. Am J Clin Nutr 1994;60:725-9.
25. Datta DB. A comprehensive introduction to membrane biochemistry. Madison (WI): Floral Publishing; 1987; p. 77-165.
26. Kamal-Eldin A, Andersson R. A multivariate study of the correlation between tocopherol content and fatty acid composition in vegetable oils. J Am Oil Chemists Soc 1997;74:375-80.
27. Esko JD, Raetz CR. The enzymes. Boyer PD, editor. Vol. 16. New York (NY): Academic Press; 1983. p. 207-53.
28. Higgs GA, Moncada S, Vane JR. Eicosanoids in inflammation. Ann Clin Res 1984;16:287-99.
29. Howell MA. Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer 1974;29:328-36.
30. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975;15:617-31.
31. Blair A, Fraumeni JF Jr. Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 1978;61:1379-84.
32. Kolonel LN, Hankin JH, Lee J, Chu SY. Nomura AM, Hinds MW. Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 1981; 44:332-9.
33. Rose DP, Boyer AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986;58:2363-71.
34. Hursting SD, Thornquist M, Henderson MM. Types of dietary fat and the incidence of cancer at five sites. Prev Med 1990;19:242-53.
35. Koo LC, Mang OW, Ho JH. An ecological study of trends in cancer incidence and dietary changes in Hong Kong. Nutr Cancer 1997;28: 289-301.
36. Bakker N, van't Veer P, Zock PL. Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. EURAMIC Study Group. Int J Cancer 1997;72:587-91.
37. Staessen L, De Bacquer D, De Henauw S, De Backer G, Van Peteghem C. Relation between fat intake and mortality: an ecological analysis in Belgium. Eur J Cancer Prev 1997;6:374-81.
38. Rotkin ID. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep 1977;61:173-80.
39. Schuman LM, Mandel JS, Radke A, Seal U, Halberg F. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case-control study, 1976-1979. In: Magnus K, editor. Trends in cancer incidence: causes and implications, Washington (DC): Hemisphere Publishing Corp.; 1982. p. 345-54.
40. Graham S, Haughey B, Marshall J, Priore R, Byers T, Rzepka T, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 1983;70:687-92.
41. Heshmat MY, Kaul L, Kovi J, Jackson MA, Jackson AG, Jones GW, et al. Nutrition and prostate cancer: a case-control study. Prostate 1985;6: 7-17.
42. Mishina T, Watanabe H, Araki H, Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 1985;6:423-36.
43. Talamini R, La Vecchia C, Decarli A, Negri E, Franceschi A. Nutrition, social factors and prostatic cancer in a Northern Italian population. Br J Cancer 1986;53:817-21.
44. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987;78:869-74.
45. Ohno Y, Yoshida O, Oishi K, Okada K, Yamabe H, Schroeder FH. Dietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res 1988;48:1331-6.
46. Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 1988;127:999-1012.
47. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer 1989;64:605-12.
48. Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostatic cancer: a case-control study. Prostate 1990;17:189-206.
49. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special reference to aggressive tumors. Cancer Causes Control 1991;2: 85-94.
50. Bravo MP, Castellanos E, del Rey Calero J. Dietary factors and prostatic cancer. Urol Int 1991;46:163-6.
51. Walker AR, Walker BF, Tsotetsi NG, Sebitso C, Siwedi D, Walker AJ. Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 1992;65:438-41.
52. Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E. Diet and prostatic cancer: a case-control study in northern Italy. Nutr Cancer 1992;118:277-86.
53. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652-61.
54. Rohan TE, Howe GR, Burch JD, Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control 1995;6:145-54.
55. Gronberg H, Damber L, Damber JE. Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data. J Urol 1996;155: 969-74.
56. Andersson SO, Wolk A, Bergstrom R, Giovannucci E, Lindgren C, Baron J. Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 1996;68:716-22.
57. Ewings P, Bowie C. A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer 1996;74:661-6.
58. Ghadirian P, Lacroix A, Maisonneuve P, Perret C, Drouin G, Perrault JP, et al. Nutritional factors and prostate cancer: a case-control study of French Canadians in Montreal, Canada. Cancer Causes Control 1996;7: 428-36.
59. Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer 1997;76:678-87.
60. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: ω-3 and ω-6 fatty acids and the risk of prostate cancer. Int J Cancer 1997;71:545-51.
61. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 1979;53:149-55.
62. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984;120:244-50.
63. Severson RK, Nomura AM. Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-60.
64. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604.
65. Hsing AW, McLaughlin JK. Shuman LM, Bjelke E, Gridley G, Wacholder S, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 1990;50:6838-40.
66. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993;85:1571-9.
67. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994;5:276-82.
68. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer [published erratum appears in J Natl Cancer Inst 1994;86:728]. J Natl Cancer Inst 1994;86:281-6.
69. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25 708 Norwegian men. Int J Cancer 1997; 73:634-8.
70. Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler JL, Sandier RS. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 1996;5:889-95.
71. Alberg AJ, Kafonek S, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ. Fatty acid levels and the subsequent development of prostate cancer [abstract]. Proc Am Assoc Cancer Res 1996;37:281.
72. United States Department of Agriculture. Nutrient data-base for standard reference, release 10. Bethesda (MD): USDA Human Nutrition Information Service: 1992.
73. Chyou PH, Nomura AM, Stemmermann GN, Kato I. Prospective study of serum cholesterol and site-specific cancers. J Clin Epidemiol 1992;45: 287-92.
74. Hiatt RA, Fireman BH. Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 1986;39:861-70.
75. Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, et al. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 1988;48:452-8.
76. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39000 men and women. J Clin Epidemiol 1988;41:519-30.
77. Smith GD, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA 1992;267:70-6.
78. Slattery ML, Schumacher MC, West DW, Robinson LM, French TK. Food consumption trends between adolescent and adult years and subsequent risk of prostate cancer. Am J Clin Nutr 1990;52:752-7.
79. Shils ME, Olson JA, Shike M, editors. Modern nutrition in health and disease. 8th ed. Philadelphia (PA); Lea & Febiger; 1994.
80. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis to aggressive tumors. Cancer Causes Control 1991;2: 85-94.
81. Schrauzer GN, White DA, Schneider CJ. Cancer mortality studies - III: statistical associations with dietary selenium intakes. Bioinorg Chem 1977;7:23-31
82. Feustel A, Wennrich R. Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammations. Prostate 1986;8:75-9.
83. Whelan P, Walker BE, Kelleher J. Zinc, vitamin A and prostatic cancer. Br J Urol 1983;55:525-8.
84. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984;120:244-50.
85. Severson RK, Nomura AM, Grove JS, Stemmermann GN. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-60.
86. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994;5:276-82.
87. Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58:442-7.
88. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987;78:869-74.
89. Talamini R, La Vecchia C, Decarli A, Negri E, Franceschi A. Nutrition, social factors and prostatic cancer in a Northern Italian population. Br J Cancer 1986;53:817-21.
90. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer 1989;64:605-12.
91. Walker AR, Walker BF, Tsotetsi NG, Sebitso C, Siwodi D, Walker AJ. Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 1992;65:438-41.
92. Committee on Diet, Nutrition and Cancer. Diet, nutrition and cancer. Washington (DC): National Academy Press; 1982. p.13-2 to 13-3.
93. Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res 1985;150;33-41.
94. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997;57:195-8.
95. Rivenson A, Silverman J. The prostatic carcinoma in laboratory animals: a bibliographic survey from 1900 to 1977. Invest Urol 1979:16;468-72.
96. Dunning WF. Prostatic cancer in the rat. Natl Cancer Inst Monogr 1963;12:351-70.
97. Pollard M. Spontaneous prostate adenocarcinomas in aged germfree Wistar rats. J Natl Cancer Inst 1973;51:1235-41.
98. Fortner JG. The influence of castration on spontaneous tumorigenesis in the Syrian (Golden) hamster. Cancer Res 1961;21:1491-8.
99. Coffey DS. Androgen action and the sex accessory tissues. In: Knobil E, Neill JD, Ewing LL, editors. The physiology of reproduction. New York (NY): Raven Press; 1988. p. 1081-118.
100. Spring-Mills E, Krall A. Functional anatomy of the prostate. In: Hafez ES, Spring-Mills E, editors. Prostate carcinoma: biology and diagnosis. Hingham (MA): Martinus-Nijhoff; 1981. p. 5-12.
101. Nielsen SW. Canine and feline neoplasia. In: Melby EC Jr, editor. Handbook of laboratory animal science. Vol. 3. Cleveland (OH): CRC Press; 1976. p. 892-932.
102. Leav I, Ling GV. Adenocarcinoma of the canine prostate. Cancer 1968;22:1329-45.
103. Engle ET, Stout AP. Spontaneous primary carcinoma of the prostate in a monkey (Macaco mullatta). Am J Cancer 1940;39:334-7.
104. Horning ES. Induction of glandular carcinomas of the prostate in the mouse; preliminary communication. Lancet 1946;2:829-30.
105. Mirand EA, Staubitz WJ. Prostatic neoplasms of the Wistar rat induced with 20-methylcholanthrene. Proc Soc Exp Biol Med 1956;93:457-62.
106. Hirose F, Takizawa S, Watanabe H, Takeichi N. Development of adenocarcinoma of the prostate in ICR mice locally irradiated with X-rays. Gann 1976;67:407-11.
107. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977;37: 1929-33.
108. Kroes R, Beems RB, Bosland MC, Bunnik GS, Sinkeldam EJ. Nutritional factors in lung, colon, and prostate carcinogenesis in animal models. Fed Proc 1986;45:136-41.
109. Pollard M, Luckert PH. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986;32:223-7.
110. Clinton SK, Palmer SS, Spriggs CE, Visek WJ. Growth of Dunning transplantable prostate adenocarcinoma in rats fed diets with various fat contents. J Nutr 1988;118:908-14.
111. Kondo Y, Homma Y, Aso Y, Kakizoe T. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/ Seg rats. Cancer Res 1994;23:6129-32.
112. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995;87:1456-62.
113. Xue L. Yang K, Newmark H, Lipkin M. Induced hyperproliferation in epithelial cells of mouse prostate by a Western-style diet. Carcinogenesis 1997;18:995-9.
114. Carroll KK, Noble RL. Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats. Carcinogenesis 1987;8: 851-3.
115. Pour PM, Groot K, Kazakoff K, Anderson K, Sobally AV. Effects of high-fat diet on the patterns of prostatic cancer induced in rats by N-nitrobis(2-oxopropyl)amine and testosterone. Cancer Res 1991;51: 4757-61.
116. Shirai T, Yamamoto A, Iwasaki S, Tamano S, Masui T. Induction of invasive carcinomas of the seminal vesicles and coagulating glands of F344 rats by administration of N-nitrosobis(2-oxopropyl)amine and followed by testosterone propionate with or without high-fat diet. Carcinogenesis 1991;12:2169-73.
117. Tobisu K, Kakizoe T, Tanaka Y, Takai K, Shirai T. Influence of dietary fat and total calorie intake on the incidence of spontaneous prostatic cancer. In: Ito N, Yamanaka T, Kakizoe T, editors. In: Procedings of the First Workshop on Prostate Cancer. Tokyo (Japan): Shalom Co.; 1990. p. 4-7.
118. Gingrich JR, Greenberg NM. A transgenic mouse prostate cancer model. Toxicol Pathol 1996;24:502-4.
119. Shibata MA, Ward JM, Devor DE, Liu ML, Green JE. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. Cancer Res 1996;56:4894-903.
120. Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 1991;18:243-54.
121. Pandalai PK, Pilat MJ, Yamazaki K, Naik H, Pienta KJ. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 1996;16:815-20.
122. Karmali RA, Reichel P, Cohen LA, Terano T, Hirai A, Tamura Y, et al. The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res 1987;7:1173-9.
123. Rose DP, Cohen LA. Effects of dietary mehaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis 1988;9:603-5.
124. Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer 1997;29:114-9.
125. Hecht JR. Dietary fat and colon cancer. In: Heber D, Kritchevsky D, editors. Dietary fats, lipids, hormones, and tumorigenesis. New York (NY): Plenum Press; 1996. p. 157-63.
126. Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G. Breast cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997;89:766-75.
127. Ames BN, Shigenaga MK. DNA damage by endogenous oxidants and mitogenesis as causes of aging and cancer. In: Molecular biology of free radical scavenging systems. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1992. p, 1-22.
128. McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, Kelloff GJ, et al. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res 1998;58:3282-8.
129. Adelman R, Saul RL, Ames BN. Oxidative damage to DNA: relation to species metabolic rate and life span. Proc Natl Acad Sci USA 1988;85: 2706-8.
130. Haegele AD, Briggs SP, Thompson HJ. Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage. Free Radic Biol Med 1994;16:111-5.
131. Alexander-North LS, North JA, Kiminyo KP, Buettner GR, Spector AA. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 1994;35:1773-85.
132. North JA, Spector AA, Buettner GR. Cell fatty acid composition affects free radical formation during lipid peroxidation. Am J Physiol 1994;267(1 Pt 1):C177-88.
133. Chung FL, Chen HJ, Nath RG. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 1996;17:2105-11.
134. de Kok TM, ten Vaarwerk F, Zwingman I, van Maanen JM, Kleinjans JC. Peroxidation of linoleic, arachidonic and oleic acid in relation to the induction of oxidative DNA damage and cytogenetic effects. Carcinogenesis 1994;15:1399-404.
135. Nagashima M, Kasai H, Yokota J, Nagamachi Y, Ichinose T, Sagai M. Formation of an oxidative DNA damage, 8-hydroxydeoxyguanosine, in mouse lung DNA after intratracheal instillation of diesel exhaust particles and effects of high dietary fat and beta-carotene on this process. Carcinogenesis 1995;16;1441-5.
136. Griveau JF, Le Lannou D. Reactive oxygen species and human spermatozoa: physiology and pathology. Int J Androl 1997;20;61-9.
137. Pulido JA, de Hoyo N, Perez-Albarsanz MA. Composition and fatty acid content of rat ventral prostate phospholipids. Biochem Biophys Acta 1986;879:51-5.
138. Sawada M, Carlson JC. Rapid plasma membrane changes in superoxide radical formation, fluidity, and phospholipase A2 activity in the corpus luteum of the rat during induction of luteolysis. Endocrinology 1991;128;2992-8.
139. Thomas JP, Maiorino M, Ursini F, Girotti AW. Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 1990;265:454-61.
140. Hodgkin MN, Pettitt TR, Martin A, Michell RH, Pemberton AJ, Wakelam MJ. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem Sci 1998;23:200-4.
141. Sies H, Murphy ME. Role of tocopherols in the protection of biological systems against oxidative damage. J Photochem Photobiol B 1991;8: 211-8.
142. McLaughlin PJ, Weihrauch JL. Vitamin E content of foods. J Am Diet Assoc 1979;75:647-65.
143. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, Mordan LJ. γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc Natl Acad Sci U S A 1993;90:1771-5.
144. 2 and their formation in rat insulinoma (RINm5F) cells. Free Radic Biol Med 1995; 19:259-69.
145. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-83.
146. Mitchell GV, Grundel E, Jenkins MY. Replacement of dietary fat with fat-free margarine alters vitamin E storage in rats. Ann N Y Acad Sci 1997;819:236-8.
147. Sies H, Stahl W. Lycopene: antioxidant and biological effects and its bioavailability in the human. Proc Soc Exp Biol Med 1998;218:121-4.
148. Kok FJ, van Poppel G, Melse J, Verheul E, Schouten EG, Kruyssen DH, et al. Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis? Atherosclerosis 1991;31: 85-90.
149. Levander OA, Beck MA. Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol Trace Elem Res 1997; 56:5-21.
150. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6.
151. Hayes RB, Bogdanovicz JF, Schroeder FH, De Bruijn A, Raatgever JW, Van der Mass PJ, et al. Serum retinol and prostate cancer. Cancer 1988; 62:2021-6.
152. Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-21.
153. Heinonen OP, Albanes D, Virtamo S, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer supplementation with a-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
154. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group [published erratum appears in JAMA 1997;277:1520]. JAMA 1996;276:1957-63.
155. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274: 532-8.
156. Giovannucci E, Ashcerio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
157. Gann PH, Ma J, Giovannucci E, Willett W, Sacks F, Hennekens CN, Stampfer MJ. Prospective analysis of plasma antioxidants and prostate cancer risk [abstract]. Proc Am Assoc Cancer Res 1998;39:89.
158. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56(2 Pt 1):35-51.
159. Gu JY, Wakizono Y, Tsujita A, Lim BO, Nonaka M, Yamada K, et al. Effects of sesamin and α-tocopherol, individually or in combination, on the polyunsaturated fatty acid metabolism, chemical mediator production, and immunoglobulin levels in Sprague-Dawley rats. Biosci Biotechnol Biochem 1995;59:2198-202.
160. Dilsiz N, Celik S, Yilmaz O, Digrak M. The effects of selenium, vitamin E and their combination on the composition of fatty acids and proteins in Saccharomyces cerevisiae. Cell Biochem Funct 1997;15:265-9.
161. Bolen EJ, Sando JJ. Effect of phospholipid unsaturation on protein kinase C activation. Biochemistry 1992;31:5945-51.
162. Birt DF, Copenhaver J, Pelling JC, Anderson J. Dietary energy restriction and fat modulation of protein kinase C isoenzymes and phorbol ester binding in Sencar mouse epidermis. Carcinogenesis 1994;5: 2727-32.
163. del Carmen Boyano-Adanez M, Rodriguez D, Aradottir S, Alling C, Gustavsson L. Protein kinase C-mediated phospholipase D activity is increased by linolenic acid supplementation in NG 108-15 cells. Biochim Biophys Acta 1994;1214:263-71.
164. Schultz AM, Henderson LE, Oroszlan S. Fatty acylation of proteins. Annu Rev Cell Biol 1988;4:611-47.
165. Yamasaki H, Mesnil M, Omori Y, Mironov N, Krutovskikh V. Intercellular communication and carcinogenesis. Mutat Res 1995;333:181-8.
166. Hayashi T, Matesic DF, Nomata K, Kang KS, Chang CC, Trosko JE. Stimulation of cell proliferation and inhibition of gap junctional communication by linoleic acid. Cancer Lett 1997;112:103-11.
167. Franke AA, Harwood PJ, Shimamoto T, Lumeng S, Zhang LX, Bertram JS, et al. Effects of micronutrients and antioxidants on lipid peroxidation in human plasma and in cell culture. Cancer Lett 1994;79:17-26.
168. de Haan LH, Bosselaers I, Jongen WM, Zwijsen RM, Koeman JH. Effect of lipids and aldehydes on gap-junctional intercellular communication between human smooth muscle cells. Carcinogenesis 1994;15:253-6.
169. Jump DB, Clarke SD, Thelan A, Liimatta M, Ren B, Badin MV. Dietary fat, genes, and human health. Adv Exp Med Biol 1997;442:167-76.
170. Virgili F, Santini MP, Canali R, Polakowska RR, Haake A, Perozzi G. Bcl-2 overexpression in the HaCaT cell line is associated with a different membrane fatty acid composition and sensitivity to oxidative stress. Free Radic Biol Med 1998;24:93-101.
171. Hamalainen E, Adlercreutz H, Puska P, Pietinen P. Diet and serum sex hormones in healthy men. J Steroid Biochem 1984;20:459-64.
172. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-26.
173. Calderon CH, Huang ZH, Gage DA, Sotomayor EM, Lopez DM. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J Exp Med 1994;180:945-58.
174. Ohata T, Fukuda K, Takahashi M, Sugimura T, Wakabayashi K. Suppression of nitric oxide production in lipopolyaccharide-stimulated macrophage cells by ω-3 polyunsaturated fatty acids. Jpn J Cancer Res 1997; 88:234-7.
175. Schini VB, Durante W, Catovsky S, Vanhoutte PM. Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1 beta in cultured vascular smooth muscle cells. J Vasc Res 1993;30: 209-17.
176. Tamir S, Burney S, Tannenbaum SR. DNA damage by nitric oxide. Chem Res Toxicol 1996;9:821-7.
177. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995;92:4392-6.
178. Xie K, Huang S, Dong Z, Fidler IJ. Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int J Oncol 1993;3:1043-8.
179. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995;92:4392-6.
180. Turek JJ, Schoenlein IA, Watkins BA, Van Alstine WG, Clark LK, Knox K. Dietary polyunsaturated fatty acids modulate responses of pigs to Mycoplasma hyopneumoniae infection. J Nutr 1996;126:1541-8.
181. Ghosh J, Myers CE Jr. Arachidonic acid metabolism and cancer of the prostate [editorial]. Nutrition 1998;14:48-9.
182. Higgs GA, Moncada S, Vane JR. Eicosanoids in inflammation. Ann Clin Res 1984;16:287-99.
183. Greenberg ER, Baron JA. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents. IARC Sci Publ 1996;139:91-8.
184. Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med 1992;327:175-81.
185. De Vries CE, Van Noorden CJ. Effects of dietary fatty acid composition on tumor growth and metastasis. Anticancer Res 1992;12:1513-22.
186. Dahiya R, Boyle B, Goldberg BC, Yoon WH, Konety B, Chen K, et al. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem Cell Biol 1992;70: 548-54.
187. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, et al. Latent carcinoma of prostate at autopsy in seven areas. Jm J Cancer 1977;20:680-8
188. Ip C, Birt DF, Rogers AE, Mettlin C, eds. Dietary fat and cancer. Progress in clinical and biological research. Vol. 222. New York (NY): Alan R. Liss; 1986.
189. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson BE. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986;76:45-8.
190. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992;339:887-9.